首页> 外文期刊>Free radical research >Comparative studies with EPR and MRI on the in vivo tissue redox status estimation using redox-sensitive nitroxyl probes: influence of the choice of the region of interest
【24h】

Comparative studies with EPR and MRI on the in vivo tissue redox status estimation using redox-sensitive nitroxyl probes: influence of the choice of the region of interest

机译:使用氧化还原氧化氮探针的体内组织氧化还原状态估计对epr和MRI的比较研究:利益区域选择的影响

获取原文
获取原文并翻译 | 示例
       

摘要

In vivo decay rates of a nitroxyl contrast agent were estimated by a MR redox imaging (MRRI) technique and compared with the decay rates obtained by the electron paramagnetic resonance spectroscopy (EPRS) and imaging (EPRI). MRRI is a dynamic imaging technique employing T1-weighted pulse sequence, which can visualise a nitroxyl-induced enhancement of signal intensity by T1-weighted contrast. EPR techniques can directly measure the paramagnetic nitroxyl radical. Both the squamous cell carcinoma (SCC) tumour-bearing and normal legs of a female C3H mouse were scanned by T1-weighted SPGR sequence at 4.7 T with the nitroxyl radical, carbamoyl-proxyl (CmP), as the contrast agent. Similarly, the time course of CmP in normal muscle and tumour tissues was obtained using a 700-MHz EPR spectrometer with a surface coil. The time course imaging of CmP was also performed by 300 MHz CW EPR imager. EPRS and EPRI gave slower decay rates of CmP compared to the MRRI. Relatively slow decay rate at peripheral region of the tumour tissues, which was found in the image obtained by MRRI, may contribute to the slower decay rates observed by EPRS and/or the EPRI measurements. To reliably determine the tissue redox status from the reduction rates of nitroxyls such as CmP, heterogenic structure in the tumour tissue must be considered. The high spatial and temporal resolution of T1-weighted MRI and the T1-enhancing capabilities of nitroxyls support the use of this method to map tissue redox status which can be a useful biomarker to guide appropriate treatments based on the tumour microenvironment. ?2018 US Government contracter.
机译:通过MR氧化还原成像(MRRI)技术估计了硝基克基造影剂的体内衰减率,并与电子顺笔共振光谱(EPRS)和成像(EPRI)获得的衰减速率进行比较。 MRRI是采用T1加权脉冲序列的动态成像技术,其可以通过T1加权对比度可视化硝基苯诱导的信号强度的增强。 EPR技术可以直接测量顺磁性硝红素基。通过用硝基根基,氨基甲酰基(CMP)为造影剂,通过T1加权SPGR序列扫描鳞状细胞癌(SCC)肿瘤轴承和雌性C3H小鼠的正常腿。类似地,使用具有表面线圈的700MHz EPR光谱仪获得正常肌肉和肿瘤组织中CMP的时间过程。 CMP的时间课程成像也由300 MHz CW EPR成像仪进行。与MRRI相比,EPRS和EPRI对CMP的速度较慢。在MRRI获得的图像中发现的肿瘤组织的外周区域的衰减率相对缓慢的衰减率可能有助于EPRS和/或EPRI测量观察到的较慢衰减率。为了可靠地确定来自诸如CMP的硝基苯的减少速率的组织氧化还原状态,必须考虑肿瘤组织中的异质结构。 T1加权MRI的高空间和时间分辨率和硝基苯的T1增强能力支持使用该方法来映射组织氧化还原状态,这可以是一种有用的生物标志物,以指导基于肿瘤微环境的适当治疗方法。 ?2018年美国政府统一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号